Enhanced production of interleukin 1-beta by mononuclear cells isolated from mucosa with active ulcerative colitis of Crohn's disease.

IL1-beta production by mononuclear cells isolated from normal and active inflammatory bowel disease mucosa was studied. Significantly more IL1-beta was produced spontaneously by mononuclear cells from the inflamed mucosa compared with those from normal colonic mucosa (median 190 pg/ml (range 45-700) v 20 pg/ml (0-165)). Stimulation with lipopolysaccharide enhanced IL1-beta production by mononuclear cells from active inflammatory bowel disease mucosa but not those from normal mucosa. Depleting the mononuclear cells of macrophages, by panning with monoclonal antibody 3C10, reduced the amount of IL1-beta produced. Enhanced IL1-beta production from the inflamed mucosa may play an important role in the mediation of many inflammatory responses. The enhanced production appears to be the result of a recruited population of cells.

[1]  J. Meer,et al.  Interleukin‐1 in the pathogenesis of fever , 1987, European journal of clinical investigation.

[2]  D. Jewell,et al.  Monocytes in inflammatory bowel disease: phagocytosis and intracellular killing. , 1980, Journal of clinical pathology.

[3]  A. Scott,et al.  Interleukin-1 induces mucus secretion from mouse intestinal explants. , 1987, International archives of allergy and applied immunology.

[4]  A. Fauci,et al.  The effects of interleukin 1 on human B cell activation and proliferation. , 1983, Journal of immunology.

[5]  L. Wysocki,et al.  "Panning" for lymphocytes: a method for cell selection. , 1978, Proceedings of the National Academy of Sciences of the United States of America.

[6]  R. Steinman,et al.  Specific antimononuclear phagocyte monoclonal antibodies. Application to the purification of dendritic cells and the tissue localization of macrophages , 1983, The Journal of experimental medicine.

[7]  S. Mizel.  Interleukin 1 and T cell activation. , 1982, Immunological reviews.

[8]  M. Bookman,et al.  Isolation and functional characterization of human intestinal mucosal lymphoid cells. , 1977, The Journal of clinical investigation.

[9]  C. Dinarello,et al.  Immunoregulatory feedback between interleukin-1 and glucocorticoid hormones. , 1986, Science.

[10]  C. Maury.  Interleukin 1 and the pathogenesis of inflammatory diseases. , 2009, Acta medica Scandinavica.

[11]  S. Mizel,et al.  Interleukin 1, a potential regulator of fibroblast proliferation. , 1982, Journal of immunology.

[12]  C. Dinarello,et al.  Biology of interleukin 1 , 1988, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[13]  P. Nowell,et al.  Dexamethasone inhibition of interleukin 1 beta production by human monocytes. Posttranscriptional mechanisms. , 1988, The Journal of clinical investigation.

[14]  J. Satsangi,et al.  Interleukin 1 in Crohn's disease. , 1987, Clinical and experimental immunology.

[15]  H Stein,et al.  Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes). , 1984, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[16]  C. Dinarello.  Interleukin-1 and the pathogenesis of the acute-phase response. , 1984, The New England journal of medicine.

[17]  T. Hopp,et al.  The cell surface receptors for interleukin-1α and interleukin-1β are identical , 1986, Nature.

[18]  W. Doe,et al.  Chronic inflammatory bowel disease--increased plasminogen activator secretion by mononuclear phagocytes. , 1982, Clinical and experimental immunology.

[19]  S. Mizel.  Interleukin l and T Cell Activation , 1982 .